Background Obesity and underweight represent classical risk factors for outcome in patients
treated for cardiovascular disease. This study describes the impact of different body mass …

Tricuspid transcatheter edge-to-edge repair (T-TEER) for severe tricuspid regurgitation (TR)
emerged as a novel treatment option for patients not amenable to surgery. However …

Background Data regarding the impact of the tricuspid valve gradient (TVG) after tricuspid
transcatheter edge-to-edge repair (TEER) are scarce. Objectives This study sought to …

BACKGROUND: We assessed the safety profile of tricuspid transcatheter edge-to-edge
repair (TEER) in patients with right ventricular (RV) dysfunction. METHODS: We identified …

Objectives: This study sought to investigate predictors of procedural success and clinical
outcomes in patients with tricuspid regurgitation (TR) at increased surgical risk undergoing …

Background Although tricuspid transcatheter edge-to-edge repair (TEER) has been
suggested to improve outcomes in patients with tricuspid regurgitation (TR), patients remain …

Background Severe tricuspid regurgitation is a debilitating condition that is associated with
substantial morbidity and often with poor quality of life. Decreasing tricuspid regurgitation …

Aim Functional or secondary tricuspid regurgitation (STR) is the most common phenotype of
tricuspid regurgitation (TR) with atrial STR (ASTR) and ventricular STR (VSTR) being …

Background Patients with severe tricuspid regurgitation (TR) exhibit high morbidity and
mortality. Tricuspid transcatheter edge-to-edge repair (T-TEER) is a rapidly evolving strategy …

Background A mismatch between tricuspid leaflet size and annular dilation is one of the
morphological features tied to the development of tricuspid regurgitation (TR). Aims We …